PEVYCOR

What this means for you

Approved and waiting on proof of use. It will register unless the applicant drops it, and its 28 Apr 2026 filing date already counts against anyone who files later.

Record

Serial number

99792686

Mark type

Stylized text

Filed

28 Apr 2026

Attorney of record

Rosaleen H. Chou

Goods and services

• Class 005 — Pharmaceuticals: Pharmaceutical preparations for the treatment of viral diseases; Pharmaceutical preparations for the treatment of liver-related diseases; Pharmaceutical preparations for the treatment of metabolic diseases; Pharmaceutical preparations for the treatment of chronic hepatitis B virus (HBV) infection; Pharmaceutical preparations for the treatment of chronic hepatitis D virus infection; Pharmaceutical preparations, namely, antivirals; Pharmaceutical preparations for the treatment of rare viral diseases; Chemical preparations for pharmaceutical or medical purposes, namely, for viral diseases; Therapeutic biological preparations for the treatment of viral diseases, liver-related diseases, metabolic diseases, chronic hepatitis B virus (HBV) infections, chronic hepatitis D virus (HDV) infections, and rare viral diseases for use in industry and science
• Class 042 — Scientific and technological services: Scientific research in the field of virology and hepatology; Research and development in the field of pharmaceutical research and development; Pharmaceutical research in the field of antiviral therapeutics; Drug discovery services; Pharmaceutical drug development services; Research and development services in the field of pharmaceutical preparations; Research and development of new products in the field of pharmaceuticals; Medical and scientific research, namely, conducting clinical trials for others; Scientific research in the nature of conducting clinical trials for others; Clinical research in the field of treatment of viral, liver, and metabolic diseases; Medical and scientific research in the field of viral, liver, and metabolic diseases; Scientific research in the field of pharmaceuticals; Pharmaceutical research services; Pharmaceutical product evaluation

Owner

• Aligos Therapeutics, Inc., South San Francisco, CA, US

Prosecution history

• 10 Sept 2026 — APPROVED FOR PUB - PRINCIPAL REGISTER
• 09 Sept 2026 — NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
• 09 Sept 2026 — EXAMINER'S AMENDMENT ENTERED
• 09 Sept 2026 — EXAMINERS AMENDMENT E-MAILED
• 09 Sept 2026 — EXAMINERS AMENDMENT -WRITTEN
• 02 Sept 2026 — ASSIGNED TO EXAMINER
• 30 Jul 2026 — NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
• 28 Apr 2026 — APPLICATION FILING RECEIPT MAILED
• 28 Apr 2026 — NEW APPLICATION ENTERED